These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17854543)

  • 1. A review of the efficacy of human Q fever vaccine registered in Australia.
    Chiu CK; Durrheim DN
    N S W Public Health Bull; 2007; 18(7-8):133-6. PubMed ID: 17854543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Q fever vaccination of children in Australia: Limited experience to date.
    Armstrong M; Francis J; Robson J; Graves S; Mills D; Ferguson J; Nourse C
    J Paediatr Child Health; 2019 Sep; 55(9):1099-1102. PubMed ID: 30604569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick DA; Izzo AA; Esterman A; Feery B; Shapiro RA
    Epidemiol Infect; 1990 Apr; 104(2):275-87. PubMed ID: 2323360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Q fever update.
    Jackson A
    Aust Vet J; 2005 Dec; 83(12):706. PubMed ID: 16395931
    [No Abstract]   [Full Text] [Related]  

  • 5. Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against
    Fratzke AP; Jan S; Felgner J; Liang L; Nakajima R; Jasinskas A; Manna S; Nihesh FN; Maiti S; Albin TJ; Esser-Kahn AP; Davies DH; Samuel JE; Felgner PL; Gregory AE
    Front Immunol; 2021; 12():653092. PubMed ID: 33815413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An economic evaluation of increased uptake in Q fever vaccination among meat and agricultural industry workers following implementation of the National Q Fever Management Program.
    Kermode M; Yong K; Hurley S; Marmion B
    Aust N Z J Public Health; 2003; 27(4):390-8. PubMed ID: 14705300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Q-vaxcelerate: A distributed development approach for a new Coxiella burnetii vaccine.
    Reeves PM; Paul SR; Sluder AE; Brauns TA; Poznansky MC
    Hum Vaccin Immunother; 2017 Dec; 13(12):2977-2981. PubMed ID: 28933682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance.
    Sellens E; Norris JM; Dhand NK; Heller J; Hayes L; Gidding HF; Willaby H; Wood N; Bosward KL
    PLoS One; 2018; 13(6):e0198421. PubMed ID: 29856835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of Coxiella burnetii vaccines in occupationally exposed populations: a systematic review and meta-analysis.
    O'Neill TJ; Sargeant JM; Poljak Z
    Zoonoses Public Health; 2014 Mar; 61(2):81-96. PubMed ID: 23721172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Components of protective immunity.
    Zhang G; Zhang Y; Samuel JE
    Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.
    Peng Y; Zhang Y; Mitchell WJ; Zhang G
    J Immunol; 2012 Nov; 189(10):4909-20. PubMed ID: 23053512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled, double-blind, cross-over, clinical trial of Q fever vaccine in selected Queensland abattoirs.
    Shapiro RA; Siskind V; Schofield FD; Stallman N; Worswick DA; Marmion BP
    Epidemiol Infect; 1990 Apr; 104(2):267-73. PubMed ID: 2182329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxiella burnetii persistence in three generations of mice after application of live attenuated human M-44 vaccine against Q fever.
    Freylikhman O; Tokarevich N; Suvorov A; Vorobiova E; Totolian A
    Ann N Y Acad Sci; 2003 Jun; 990():496-9. PubMed ID: 12860680
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
    Waag DM; England MJ; Pitt ML
    Vaccine; 1997 Nov; 15(16):1779-83. PubMed ID: 9364683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014.
    Sellens E; Norris JM; Dhand NK; Heller J; Hayes L; Gidding HF; Willaby H; Wood N; Bosward KL
    PLoS One; 2016; 11(1):e0146819. PubMed ID: 26756210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.
    Shannon JG; Heinzen RA
    Immunol Res; 2009; 43(1-3):138-48. PubMed ID: 18813881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of Q fever in Australia 1991-1994.
    Garner MG; Longbottom HM; Cannon RM; Plant AJ
    Aust N Z J Public Health; 1997 Dec; 21(7):722-30. PubMed ID: 9489189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxiella burnetii: host and bacterial responses to infection.
    Waag DM
    Vaccine; 2007 Oct; 25(42):7288-95. PubMed ID: 17825460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of Q fever vaccines against Coxiella burnetii experimental challenge in pregnant goats.
    Souriau A; Arricau-Bouvery N; Bodier C; Rodolakis A
    Ann N Y Acad Sci; 2003 Jun; 990():521-3. PubMed ID: 12860684
    [No Abstract]   [Full Text] [Related]  

  • 20. Q fever and prevention.
    Škultéty L
    Epidemiol Mikrobiol Imunol; 2020; 69(2):87-94. PubMed ID: 32819108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.